Free Trial
ASX:RMD

ResMed (RMD) Stock Price, News & Analysis

ResMed logo

About ResMed Stock (ASX:RMD)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.23 million shs
Average Volume
N/A
Market Capitalization
$34.74 billion
P/E Ratio
27.82
Dividend Yield
0.84%
Price Target
N/A
Consensus Rating
N/A

Company Overview

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Remove Ads
Receive RMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter.

RMD Stock News Headlines

ResMed announces availability of home sleep apnea test NightOwl
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
ResMed price target lowered to $280 from $290 at BofA
Is ResMed Stock Outperforming the Dow?
2 ASX healthcare shares rated as top buys
See More Headlines

RMD Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that ResMed investors own include CSL (CSL), Altium (ALU), BHP Group (BHP), Credit Corp Group (CCP), Cochlear (COH), Moderna (MRNA) and Abbott Laboratories (ABT).

Company Calendar

Ex-Dividend for 3/19 Dividend
2/11/2025
Record date for 3/19 Dividend
3/19/2025
Dividend Payable
3/19/2025
Today
4/03/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Medical Equipment
Current Symbol
ASX:RMD
CIK
N/A
Fax
N/A
Employees
9,980
Year Founded
N/A

Profitability

Trailing P/E Ratio
27.82
Forward P/E Ratio
N/A
P/E Growth
2.01
Net Income
$1.02 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.69 billion
Price / Cash Flow
106.15
Book Value
A$3.58 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,470,000,000
Free Float
N/A
Market Cap
$34.74 billion
Optionable
Not Optionable
Beta
0.69
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (ASX:RMD) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners